Ryan White Part B/ADAP

Information

The purpose of the Ryan White Part B and ADAP program is to improve the health outcomes for people living with HIV and reduce HIV-related health disparities. The Ryan White Program provides core medical and support services including emergency assistance services, housing assistance services, transportation and food assistance. The RWHAP Part B grants include a Base grant for core medical and support services; the AIDS Drug Assistance Program (ADAP) award supports FDA-approved medications to treat HIV and HIV-related infections for individuals living with HIV/AIDS who have no health insurance (public or private), insufficient health care coverage, and/or lack financial resources to get the care they need. The Ryan White grants provide a flexible structure to address the HIV/AIDS care needs of Idahoans.

Funding Composition

The Ryan White Part B/ADAP program is funded by 3 Federal grants and 1 Dedicated grant.

A chart containing the data for the funding composition pie chart.
Funding Source Percent
Federal 53.54%
Dedicated 46.46%
Last Updated On: 01/16/2025

Program Funding

Last Updated On: 01/16/2025
Grant Title
Grant Information
Dedicated
Communicable Disease Prevention Administration
Projected
$6,410,400
YTD
$3,059,010
Federal
HIV Care
Projected
$1,269,700
YTD
$218,947
Federal
Ryan White Part B Supplemental
Projected
$4,216,700
YTD
$418,024
Federal
AIDs Drug Assistance Emergency Funding
Projected
$1,900,000
YTD
$927,585
Program Total
Total
$13,796,800
YTD
$4,623,566
ALN
Fund Type
Grant Title
Projected Budget SFY 2025
YTD Expenditure SFY 2025
Dedicated
Communicable Disease Prevention Administration
$6,410,400
$3,059,010
93.917
Federal
HIV Care
$1,269,700
$218,947
93.917
Federal
Ryan White Part B Supplemental
$4,216,700
$418,024
93.917
Federal
AIDs Drug Assistance Emergency Funding
$1,900,000
$927,585
Program Total
$13,796,800
$4,623,566

Program Performance Measures

Goal 1: Increase health outcomes for eligible people living with HIV in Idaho.

Objective: By March 31, 2025,increase the percent of clients virally suppressed from 85% to 90%.

Current: Jan 2024
85
Target: Aug 2025
90
A chart containing the data from the graph for: Objective: By March 31, 2025,increase the percent of clients virally suppressed from 85% to 90%.
Date Actual Target
01/01/2024 85 90
08/01/2025 90

Performance Measures

Percent of virally suppressed ADAP clients

Current: Mar 2023
85
Target: Mar 2025
90
Current: Mar 2023
85
Target: Mar 2025
90
A chart containing the data from the graph for: Percent of virally suppressed ADAP clients
Date Actual Target
03/01/2023 85 90
03/01/2025 90

Objective: By June 30, 2025, the RWPB medical case managers will increase ART medication data to CAREWare for all current clients from 0 to 350.

Current: Oct 2024
0
Target: Jun 2025
350
A chart containing the data from the graph for: Objective: By June 30, 2025, the RWPB medical case managers will increase ART medication data to CAREWare for all current clients from 0 to 350.
Date Actual Target
10/01/2024 0 350
06/01/2025 350

Performance Measures

Number of clients with updated ART medications added to CAREWare

Current: Mar 2024
0
Target: Mar 2025
300
Current: Mar 2024
0
Target: Mar 2025
300
A chart containing the data from the graph for: Number of clients with updated ART medications added to CAREWare
Date Actual Target
03/01/2024 0 300
03/01/2025 300